Adapthealth Corp is a leading provider of home healthcare equipment and services, focused on improving the quality of life for patients with chronic conditions
The company offers a wide range of products, including respiratory devices, mobility aids, and sleep-related solutions, and is dedicated to delivering personalized care and support to patients in need. Through its extensive network of locations, Adapthealth aims to enhance patient outcomes by providing timely access to essential medical supplies and technology, as well as educational resources and professional support, ensuring that patients can manage their health effectively in the comfort of their own homes.
Shares of healthcare services provider AdaptHealth Corp. (NASDAQAHCO) jumped 28% in the morning session after the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.
Healthcare services provider AdaptHealth Corp. (NASDAQAHCO) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $856.6 million. On the other hand, the company’s full-year revenue guidance of $3.29 billion at the midpoint came in 1.2% below analysts’ estimates. Its GAAP profit of $0.34 per share was 34.8% above analysts’ consensus estimates.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQAHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSEBKD) and its peers.
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSECHE) and its peers.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQADUS) and its peers.
